2023-06-13T16:54:26-05:00 2022-09-30 910189318 MOSS ADAMS LLP 21700 OXNARD ST STE 300 WOODLAND HILLS CA 91367 990 2021-10-01 951757119 HUNTINGTON MEDICAL RESEARCH INSTITUTES HUNT 6267954343 686 SOUTH FAIR OAKS AVENUE PASADENA CA 91105 SUSAN KANE BOARD CHAIR 6267954343 2023-06-13 1 SUSAN KANE 999009999 LAUREN A HAVERLOCK P00545829 8185771900 2023-05-22 3 AAL1 IAL1 2021 2023-04-26 12:10:37Z JULIA BRADSHER 686 SOUTH FAIR OAKS AVENUE PASADENA CA 91105 12843498 0 X WWW.HMRI.ORG X 1982 CA IMPROVING LIVES THROUGH PATIENT FOCUSED SCIENTIFIC RESEARCH. 22 22 73 29 -91690 359572 13397713 5875034 865851 1137364 2239262 1781120 172039 234086 16674865 9027604 0 0 0 0 6145859 5791193 0 0 639471 7602169 7834711 13748028 13625904 2926837 -4598300 82259720 70090884 5945756 2113362 76313964 67977522 IMPROVING LIVES THROUGH PATIENT FOCUSED SCIENTIFIC RESEARCH. 0 0 8805142 1137364 HMRI'S RESEARCH PROGRAMS ARE FOCUSED ON COMMON DISEASE PROCESSES INCLUDING NEUROLOGIC (ALZHEIMER'S-MIGRAINE), CARDIOVASCULAR, LIVER AND GASTROINTESTINAL, AND MAGNETIC RESONANCE IMAGING THAT SUPPORTS RESEARCH ACROSS HMRI. IN 2021/2022 HMRI RESEARCHERS PUBLISHED PAPERS IN PEER REVIEWED JOURNALS, SERVED ON EDITORIAL BOARDS AND SCIENCE ADVISORY BOARDS, AND PRESENTED THEIR WORK AT CONFERENCES.THE MAJOR SERVICE ACCOMPLISHMENTS OF THE YEAR WERE THE ONGOING SEMINAR SERIES OPEN TO THE PUBLIC COVERING A WIDE RANGE OF TIMELY MEDICAL AND RESEARCH TOPICS, ONGOING ENROLLMENT OF STUDY PARTICIPANTS IN OUR STUDY OF BRAIN AGING. 8805142 1 1 0 0 0 0 0 0 0 1 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 60 0 1 73 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 22 22 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 1 1 CA X X THE CFO 6267954343 686 SOUTH FAIR OAKS AVENUE PASADENA CA 91105 JAMES GAMB CHAIRMAN 2.00 X X 0 0 0 SUSAN KANE VICE-CHAIR 2.00 X X 0 0 0 M HELEN BAATZ BOARD MEMBER - UNTIL 12/21 2.00 X 0 0 0 JOHN BABCOCK BOARD MEMBER 2.00 X 0 0 0 C JOSEPH CHANG BOARD MEMBER 2.00 X 0 0 0 DAVID M DAVIS BOARD MEMBER 2.00 X 0 0 0 ROGER ENGEMANN BOARD MEMBER 2.00 X 0 0 0 JAMES FEMINO BOARD MEMBER 2.00 X 0 0 0 LAWRENCE W JONES BOARD MEMBER 2.00 X 0 0 0 KATHLEEN KANE BOARD MEMBER 2.00 X 0 0 0 DANIEL KIMBELL BOARD MEMBER 2.00 X 0 0 0 GEORGE D LEAL BOARD MEMBER - UNTIL 12/21 2.00 X 0 0 0 ALEXANDRA LEVINE BOARD MEMBER 2.00 X 0 0 0 PETER M MENARD BOARD MEMBER 2.00 X 0 0 0 JOHN MOTHERSHEAD BOARD MEMBER 2.00 X 0 0 0 JACQUIE OCHOA-ROSELLINI BOARD MEMBER 2.00 X 0 0 0 TERRY PERUCCA BOARD MEMBER 2.00 X 0 0 0 SONIA SINGLA BOARD MEMBER 2.00 X 0 0 0 WILLIAM E THOMSON BOARD MEMBER 2.00 X 0 0 0 CAMERON BOSWELL BOARD MEMBER 2.00 X 0 0 0 BARBARA HUNT BOARD MEMBER - UNTIL 7/22 2.00 X 0 0 0 SANDRA SHARP BOARD MEMBER 2.00 X 0 0 0 UMA SHRIVASTAVA BOARD MEMBER 2.00 X 0 0 0 RICK WENTZEL DIRECTOR - AS OF 9/22 2.00 X 0 0 0 JULIA BRADSHER PRESIDENT AND CEO 40.00 X 444540 0 38472 WENDY WELCH-KELLER CHIEF OF STAFF, BOARD SECRETARY 40.00 X 86529 0 14872 GABRIEL RINCON CFO - AS OF 7/2022 40.00 X 0 0 0 ROBERT KLONER CSO, DIRECTOR CARDIOVASCULAR 40.00 X 393108 0 10507 SUSIE BERRY VP, DEVELOPMENT 40.00 X 150690 0 19724 MARK DIXON VP, LABORATORY AND FACILITY 40.00 X 153397 0 14003 ANJU VASUDEVAN SCIENTIFIC DIRECTOR NEUROSCIENCE 40.00 X 176308 0 23492 NICOLE PURCELL CARDIOVASCULAR SIGNALING PROGRAM /EDUCATION 40.00 X 177422 0 14860 TAMARA SULLIVAN-SMITH VP, RESEARCH/ADMIN - UNTIL 2/22 40.00 X 157962 0 14208 ARMANDO NEVAREZ FORMER VP, FIN/ACCTG - UNTIL 6/21 40.00 X 114362 0 9063 MICHAEL HARRINGTON FORMER SCIENTIFIC DIR. - UNTIL 6/21 40.00 X 116050 0 7245 1970368 0 166446 9 1 1 0 DLC 21800 OXNORD ST SUITE 980 WOODLAND HILLS CA 91367 ACCOUNTING SERVICES 647103 CMBS PO BOX 60049 ARCADIA CA 910660049 COMPUTER CONSULTING SERVICES 251371 SEYFARTH SHAW LLP 3807 COLLECTIONS CENTER DRIVE CHICAGO IL 60693 ATTORNEY SERVICES 178273 FRAME 42 MARKETING 1533 SQUIRREL LAKE COURT MATTHEWS NC 28105 MARKETING SERVICES 142922 HARBOUR BUILDING MAINTENANCE 5011 ARGOSY AVE STE 11 HUNTINGTON BEACH CA 92649 JANITORIAL SERVICES 134746 5 2903198 2971836 5875034 MEDICAL RESEARCH 541700 1137364 1137364 1137364 1315640 -91690 1407330 8256 8256 194316 0 194316 194316 194316 4281374 3815894 465480 465480 465480 OTHER INCOME 901101 31514 31514 31514 9027604 1137364 -91690 2106896 1097625 411090 662434 24101 3322322 2272270 825877 224175 597617 362813 201218 33586 481548 292348 162137 27063 292081 177322 98344 16415 1793971 395855 1398116 98128 98128 34998 34998 1237898 1198489 33793 5616 1053748 485444 290847 277457 665905 579337 79909 6659 70867 43023 23861 3983 1441073 1273376 156846 10851 283101 246298 33972 2831 REPAIRS, MAINTENANCE, A 650194 565669 78023 6502 RESEARCH AND OTHER SUPP 481593 481593 TAXES AND LICENSES 23235 20215 2788 232 13625904 8805142 4181291 639471 286 0 4946345 4686352 7520110 5157705 253554 385085 111962 147917 45361809 13196546 32535409 32165263 31726791 23126304 4998158 4216838 167105 205420 82259720 70090884 1549030 1473168 144917 3634 4251809 636560 5945756 2113362 X 50418042 45946671 25895922 22030851 76313964 67977522 82259720 70090884 X -4598300 -7445081 3706939 X 0 1 X 1 1 1 X 6933210 7359433 5235769 13397713 5875034 38801159 6933210 7359433 5235769 13397713 5875034 38801159 9646409 29154750 1304802 1355136 1026043 1292729 1609902 6588612 132323 132323 6236 31514 37750 45559844 3507404 0.63990 0.58980 X 0.58980 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 36414587 1165089 5335047 3584499 28660130 33630474 7069040 4284927 36414587 28632972 3838370 2686172 1527040 33630474 30494450 1197434 3058912 28632972 34262068 602660 2478825 6849103 30494450 0.49000 0.23000 0.28000 0 0 2506062 2506062 31091667 5620460 25471207 2638096 1249300 1388796 7217211 6012243 1204968 1217551 691222 314543 1594230 32165263 LIMITED PARTNERSHIPS 4216838 C 4216838 ACCRUED PENSION COST 636560 636560 X 5254464 -7445081 3706939 -3738142 8992606 34998 34998 9027604 13590906 0 13590906 34998 34998 13625904 PART V, LINE 4: THE ENDOWMENT CONSISTS OF THREE TYPES OF FUNDS: (1) UNRESTRICTED FUNDS ARE FOR UNRESTRICTED USE AT HMRI'S DISCRETION, CURRENTLY SPENDING FROM SUCH FUNDS SUPPORT OPERATIONS. (2) PERMANENT ENDOWMENT FUNDS WERE DONATED WITH INSTRUCTIONS FOR THE CORPUS TO REMAIN INTACT AND INCOME EARNED FROM APPRECIATION IS AVAILABLE FOR CERTAIN OPERATIONAL USES. (3) THE INCOME FROM THE PERMANENT ENDOWMENT FUNDS ARE REPRESENTED AS TEMPORARILY RESTRICTED UNTIL APPROPRIATED FOR EXPENDITURE BY THE ORGANIZATION. PART X, LINE 2: MANAGEMENT BELIEVES THAT IS HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN AFFECTING ITS ANNUAL FILING REQUIREMENTS AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS. HMRI WOULD RECOGNIZE FUTURE ACCRUED INTEREST AND PENALTIES RELATED TO UNRECOGNIZED TAX BENEFITS AND LIABILITIES IN INCOME TAX EXPENSE IF SUCH INTEREST AND PENALTIES INCURRED. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN ACCRUED PENSION COST 3,615,249. INVESTMENTS IN PARTNERSHIPS 91,690. X X X X 0 0 0 0 0 0 0 0 0 JULIA BRADSHER PRESIDENT AND CEO 444540 0 0 0 0 0 35742 0 2730 0 483012 0 0 0 ROBERT KLONER CSO, DIRECTOR CARDIOVASCULAR 393108 0 0 0 0 0 9957 0 550 0 403615 0 0 0 ANJU VASUDEVAN SCIENTIFIC DIRECTOR NEUROSCIENCE 176308 0 0 0 0 0 14800 0 8692 0 199800 0 0 0 NICOLE PURCELL CARDIOVASCULAR SIGNALING PROGRAM /ED 177422 0 0 0 0 0 14243 0 617 0 192282 0 0 0 TAMARA SULLIVAN-SMITH VP, RESEARCH/ADMIN - UNTIL 2/22 157962 0 0 0 0 0 12720 0 1488 0 172170 0 0 0 SUSIE BERRY VP, DEVELOPMENT 150690 0 0 0 0 0 11118 0 8606 0 170414 0 0 0 MARK DIXON VP, LABORATORY AND FACILITY 153397 0 0 0 0 0 12400 0 1603 0 167400 0 0 0 ARMANDO NEVAREZ FORMER VP, FIN/ACCTG - UNTIL 6/21 114362 0 0 0 0 0 8403 0 660 0 123425 0 0 0 MICHAEL HARRINGTON FORMER SCIENTIFIC DIR. - UNTIL 6/21 116050 0 0 0 0 0 7245 0 0 0 123295 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B AN IN-DEPTH REVIEW OF THE FORM 990 IS DONE BY THE PRESIDENT AND CEO, AND THE CFO. THE AUDIT COMMITTEE REVIEWS THE 990 DRAFT AND ADDRESSES ANY QUESTIONS PRIOR TO BEING SENT TO THE GOVERNING BODY FOR FINAL REVIEW. FORM 990, PART VI, SECTION B, LINE 12C A CONFLICT OF INTEREST AND A RELATED PARTY QUESTIONNAIRE IS SENT OUT TO ALL BOARD MEMBERS ANNUALLY TO DISCLOSE ANY CIRCUMSTANCES THAT COULD GIVE RISE TO CONFLICTS OF INTEREST. THE GOVERNANCE COMMITTEE OF THE BOARD REVIEWS AND MAKES RECOMMENDATIONS TO THE FULL BOARD FOR ACTION, IF ANY. FORM 990, PART VI, SECTION B, LINE 15A AN ANNUAL PERFORMANCE REVIEW IS CONDUCTED THAT INCLUDES A 360 DEGREE REVIEW WITH INPUT FROM ALL BOARD MEMBERS AND DIRECT REPORTS. ALL DATA IS REVIEWED BY THE EXECUTIVE COMMITTEE WITH THE CEO. SALARY IS BASED ON COMPARISONS OF SALARIES AT SIMILAR ORGANIZATIONS AND COST OF LIVING SINCE LAST INCREASE. SALARY IS REVIEWED ANNUALLY. FORM 990, PART VI, SECTION C, LINE 19 OUR BYLAWS AND ARTICLES OF INCORPORATION ARE AVAILABLE UPON REQUEST. OUR CONFLICT-OF-INTEREST POLICY IS AVAILABLE UPON REQUEST. THE AUDITED FINANCIAL STATEMENTS ARE PUBLISHED ON HMRI'S WEBSITE. FORM 990, PART VI, SECTION A, LINE 1A THE BOARD OF DIRECTORS DELEGATES THE POWER OF AUTHORITY TO THE EXECUTIVE COMMITTEE IN ACCORDANCE WITH THE BYLAWS. THE EXECUTIVE COMMITEE THEN HAS THE AUTHORITY TO CARRY OUT GOVERNANCE AS OUTLINED IN THE BYLAWS AND AS DELEGATED. THE EXECUTIVE COMMITTEE IS THE ONLY COMMITTEE WITH THE AUTHORITY TO ACT IN BEHALF OF THE GOVERNING BODY. FORM 990, PART XI, LINE 9: CHANGE IN ACCRUED PENSION COST 3,615,249. INVESTMENTS IN PARTNERSHIPS 91,690. CHARITABLE REMAINDER TRUST (1) CA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0